Clinical Trials Logo
  1. Home
  2. Spondylarthropathies
  3. NCT04540432

Evolution of Intestinal Microbiota in Patients With Juvenile Spondylarthropathy According to Typology of Treatment — MESAJ  

Spondylarthropathies Clinical Trial

Official title:
Descriptive Study on the Evolution of Intestinal Microbiota Profiles in Patients With Juvenile Spondylarthropathy According to the Typology of Treatment and Response to it: A Descriptive, Prospective Pilot Study

Clinical Trial Summary

Idiopathic juvenile arthritis includes 20% of patients with arthritis with enthesitis or juvenile spondyloarthropathy. This is treated with anti-inflammatory drugs and then followed by biotherapy with DMARDs (Drugs Modifying the Activity of Rheumatic Disease) if the former are insufficient. Methotrexate (MTX) may also be used before these biotherapies. Recently, in adults, a particular profile of intestinal microbiota has been shown to alter the availability of MTX making it in efficient. Knowing that pediatric patients with juvenile spondyloarthropathy have an imbalance of their intestinal flora (dysbiosis) the investigators wanted to explore whether DMARDs could have a similar impact on the microbiota of these young patients and alter the response to treatment.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04540432
Study type Interventional
Source Centre Hospitalier Universitaire de Nimes
Contact Tu-Anh TRAN, Professor
Phone +33 4 66 32 86
Email tu.anh.tran@chu-nimes.fr
Status Recruiting
Phase N/A
Start date September 22, 2021
Completion date June 28, 2027
View Details
See also
  Status Clinical Trial Phase
Completed NCT03173144 - Chronic Inflammatory Disease, Lifestyle and Treatment Response
Recruiting NCT01216631 - Seronegative Oligoarthritis of the Knee Study (SOKS) Phase 2
Completed NCT00133315 - TNFalfa Blocking Treatment of Spondylarthropathies Phase 4
Active, not recruiting NCT03456206 - Chronic Inflammatory Disease, Lifestyle and Risk of Disease
Completed NCT02436785 - Do Inflammatory Arthritis Inpatients Receiving Group Music Therapy Improve Pain Compared to Music Listening? N/A
Completed NCT03358134 - Mechanism of Action of Anti-IL17 Therapy in Peripheral Spondyloarthritis Phase 3
Withdrawn NCT00298012 - Methotrexate in the Treatment of Axial Spondyloarthritis Phase 4
Recruiting NCT02809781 - A Pilot Study of MSCs Iufusion and Etanercept to Treat Ankylosing Spondylitis Phase 2/Phase 3
Completed NCT02098694 - Physiotherapy-led Outpatient Clinic for Patients With Spondyloarthritis N/A
Completed NCT00591201 - Efficacy, Safety, and Tolerability Study of Infliximab in Juvenile Spondyloarthropathies Phase 2/Phase 3
Completed NCT03190603 - Effects of Nonsteroidal Anti-inflammatory Drug (NSAID) on Inflammatory Lesion of Axial Spondyloarthritis Phase 4
Completed NCT01604629 - Evaluation of a Protocol for Dose Reduction in Patients With Spondylarthropathies and Clinical Remission With Anti-TNF Phase 4
Active, not recruiting NCT06402396 - Assessing Pain by the painDETECT Questionnaire (PDQ)
Completed NCT04709354 - Clinical and Dermoscopic Comparison of Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriasis Patients' Nails